Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region

Objectives: We present the survey data on molecular testing and its implications among lung cancer specialists in South Asian Association for Regional Cooperation (SAARC) region. Material Methods: An online Google form was developed that could be completed <5 min. This circulated to oncologists who had been actively participated our academic activities this were collected over an 11 day period November 2020. Results: 354 responders from 8 SAARC countries, 58.9% (209/354) being medical oncologists, 30.1% (107/354) radiation oncologists. Nearly 50% of seeing patients second wave coronavirus disease 2019 89% seen reduction their during first wave. Biomarker advanced using next-generation sequencing as preferred method more (76%) compared all other (24%); (Pearson Chi-square = 0.006). The practice waiting report before starting line treatment 55.4% corporate/private hospitals 27% government/charity hospital sectors 0.015). A total 89.6% believed targeted therapy has resulted improved overall survival cancer. Conclusion: Educational need strengthened so follow comprehensive NGS appropriate settings, shown by